New Ways to Treat Cancer
Cancer Therapeutics
This program aims to find and develop new medicines and diagnostic tools for people with solid tumors, including breast cancer.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11099842 on NIH RePORTER |
What this research studies
This program brings together experts to discover and create new cancer treatments and better ways to identify cancer. Our goal is to translate promising laboratory findings into clinical trials that can make a real difference for patients with solid tumors. We are focusing on developing novel drugs and identifying biological markers that can help guide treatment decisions. This work combines cutting-edge basic science with extensive experience in running clinical trials to bring new options to patients.
Who could benefit from this research
Good fit: This research is ultimately designed to benefit patients with solid tumors, including those with breast cancer, who may be candidates for future clinical trials.
Not a fit: Patients without solid tumors or those not seeking new treatment options may not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective treatments and improved diagnostic methods for various solid tumors, potentially offering better outcomes for patients.
How similar studies have performed: This program builds upon decades of experience in drug development and clinical trials, including those that have led to FDA-approved agents for breast cancer.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Gray, Nathanael Schiander — Stanford University
- Study coordinator: Gray, Nathanael Schiander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.